BLTE

Belite Bio, Inc - American Depositary Shares (BLTE)

About Belite Bio, Inc - American Depositary Shares (BLTE)

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$154.00

Daily low

$142.13

Price at open

52 Week High

$200.00

52 Week Low

$102.00

Market cap

6.2B

Dividend yield

Volume

205

Avg. volume

153,535

P/E ratio

-56.31

Belite Bio, Inc - American Depositary Shares News